These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


371 related items for PubMed ID: 2883152

  • 1. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H.
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract] [Full Text] [Related]

  • 2. Sulfasalazine and new analogues.
    Friedman G.
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract] [Full Text] [Related]

  • 3. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT.
    N Z Med J; 1986 Oct 08; 99(811):757-9. PubMed ID: 2877428
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
    Maier KP.
    Dtsch Med Wochenschr; 1992 Oct 16; 117(42):1614-5. PubMed ID: 1356747
    [No Abstract] [Full Text] [Related]

  • 6. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL.
    Gastroenterol Clin North Am; 1989 Mar 16; 18(1):35-42. PubMed ID: 2563990
    [Abstract] [Full Text] [Related]

  • 7. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW, Gales BJ.
    Clin Pharm; 1992 Jun 16; 11(6):514-28. PubMed ID: 1600685
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Will there be a next generation of sulfasalazine?
    Goldman P.
    Gastroenterology; 1982 Nov 16; 83(5):1138-41. PubMed ID: 6126420
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
    Lauritsen K.
    Dan Med Bull; 1989 Sep 16; 36(4):378-93. PubMed ID: 2572403
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.